Zhonghong Medical H1 2026 Net Profit Surges Over 26-Fold

Key Facts

1Zhonghong Medical reported a net profit surge of over 26-fold in its interim report for the first half of 2026.

In a move reflecting the recovery of China's medical supplies sector, Zhonghong Pulin Medical Products announced an extraordinary surge in its financial results for the first half of 2026. According to reports, net profit attributable to shareholders skyrocketed by 2,662.38% to reach RMB 159 million, while revenue grew by 19.46% to RMB 1.478 billion. This robust growth was primarily driven by rising selling prices for health protective gloves and optimized management of raw materials and production processes.

On the operational front, the health protection products segment generated RMB 1.352 billion in revenue with a gross margin of 23.68%, marking a significant year-on-year increase of 14.70 percentage points. These results arrive amid mixed Chinese economic signals; per market data, industrial production grew by 5.2% in August 2026, while the unemployment rate stood at 5.3% according to official statistics released on September 15.

Looking ahead, the company continues to expand its global footprint with the steady progress of its Indonesian manufacturing base, which is expected to add an annual capacity of 8 to 10 billion nitrile gloves. While specific price data for the stock (300981.SZ) is currently unavailable, investors are monitoring the sustainability of these high margins, especially as China's house price index showed a 3% decline in the latest reading as of September 15, 2026.